Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
作者更正:溶瘤病毒疗法 DNX-2401 联合帕博利珠单抗治疗复发性胶质母细胞瘤:一项 1/2 期试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03895-1
Nassiri, Farshad; Patil, Vikas; Yefet, Leeor S; Singh, Olivia; Liu, Jeff; Dang, Rachel M A; Yamaguchi, Takafumi N; Daras, Mariza; Cloughesy, Timothy F; Colman, Howard; Kumthekar, Priya U; Chen, Clark C; Aiken, Robert; Groves, Morris D; Ong, Shirley S; Ramakrishna, Rohan; Vogelbaum, Michael A; Khagi, Simon; Kaley, Thomas; Melear, Jason M; Peereboom, David M; Rodriguez, Analiz; Yankelevich, Maxim; Nair, Suresh G; Puduvalli, Vinay K; Aldape, Kenneth; Gao, Andrew; López-Janeiro, Álvaro; de Andrea, Carlos E; Alonso, Marta M; Boutros, Paul; Robbins, Joan; Mason, Warren P; Sonabend, Adam M; Stupp, Roger; Fueyo, Juan; Gomez-Manzano, Candelaria; Lang, Frederick F; Zadeh, Gelareh